Alterations in the force‐frequency relationship by <i>tert‐</i> butylbenzohydroquinone, a putative SR Ca<sup>2+</sup> pump inhibitor, in rabbit and rat ventricular muscle

S. Baudet(Hôpital Laennec), Hervé Le Marec(Centre National de la Recherche Scientifique), Jacques Noireaud(Inserm), Emmanuelle Do(Hôpital Laennec)

British Journal of Pharmacology

January 1, 1996

10.1111/j.1476-5381.1996.tb15185.x

Cited by 10

Related Papers

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

|Heart Rhythm|2011|1.5k

Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death

|Nature|2003|961

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)

|EP Europace|2011|904

Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome

|Circulation|2010|850

Cardiac conduction defects associate with mutations in SCN5A

|Nature Genetics|1999|638